{"id":1206,"date":"2024-01-24T00:49:04","date_gmt":"2024-01-23T21:49:04","guid":{"rendered":"https:\/\/www.sightsciences.com\/ous\/?p=1059"},"modified":"2024-05-27T09:47:34","modified_gmt":"2024-05-27T06:47:34","slug":"sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital","status":"publish","type":"post","link":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/","title":{"rendered":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital"},"content":{"rendered":"<div class=\"ndq-section\">\n<div id=\"ndq-content\" class=\"row ndq-8616\">\n<div class=\"column large-12\">\n<div class=\"region region-content\">\n<div class=\"hidden\" data-drupal-messages-fallback=\"\"><\/div>\n<div id=\"block-nir-pid4158-content\" class=\"block--system-main-block block--system-main-block--8616 block--content--system-main-block block--content--system-main-block--8616 block--d3e5cab3-701e-469f-8150-a0c2ef34d4c7 block--d3e5cab3-701e-469f-8150-a0c2ef34d4c7--8616 block block-system block-system-main-block\">\n<article class=\"node node--nir-news--full node--type-nir-news node--view-mode-full node--promoted\">\n<div class=\"file-link pdf-file-link\"><span class=\"file file--mime-application-pdf file--application-pdf\"><a href=\"\/wp-content\/uploads\/sites\/3\/2024\/01\/Sight-Sciences-Announces-the-Closing-of-up-to-65-Million-Senior-Secured-Credit-Facility-with-Hercules-Capital.pdf\" target=\"_blank\" rel=\"noopener\">PDF Version<\/a><\/span><\/div>\n<p>&nbsp;<\/p>\n<div class=\"node__content\">\n<div class=\"box__wrap\"><\/div>\n<h3 class=\"subhead-gnw\">Refinancing replaces prior senior credit facility<\/h3>\n<p>MENLO PARK, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) &#8212; Sight Sciences, Inc. (Nasdaq: SGHT)<br \/>\n(\u201cSight Sciences\u201d), an eyecare technology company focused on developing and commercializing<br \/>\ninnovative technology intended to transform care and improve patients\u2019 lives, today<br \/>\nannounced the closing of an up to $65 million senior secured credit facility with Hercules<br \/>\nCapital, Inc. (NYSE: HTGC) (\u201cHercules\u201d), a leader in customized debt financing for companies<br \/>\nin life sciences and technology-related markets. The transaction included the immediate draw<br \/>\nof $35 million, the net proceeds of which the Company used to pay off the principal amount<br \/>\nof the Company\u2019s indebtedness to its previous secured lender.<\/p>\n<p>\u201cThis new facility further strengthens our balance sheet and enhances our ability to execute<br \/>\nour strategic plan,\u201d said Ali Bauerlein, Chief Financial Officer of Sight Sciences. \u201cWe are<br \/>\nexcited to partner with the Hercules team and are pleased to extend our cash runway and<br \/>\nexpand financial flexibility through the support and confidence of a leading growth medtech<br \/>\nlender like Hercules. We feel Hercules is an ideal partner for us moving forward as we scale<br \/>\nour business over the coming years.\u201d<\/p>\n<p>\u201cThis capital commitment from Hercules aims to help Sight Sciences deliver on its important<br \/>\nmission to transform the treatment of eye diseases by treating the underlying causes,\u201d said<br \/>\nLake McGuire, Managing Director at Hercules Capital. \u201cWe are proud to partner with the Sight<br \/>\nSciences team and provide them with improved financial flexibility.\u201d<\/p>\n<p><strong>Key Credit Facility Terms:<\/strong><\/p>\n<ul>\n<li style=\"text-align: justify;\">$35 million funded at loan closing, with up to an<br \/>\nadditional $30 million potentially available (subject to certain conditions as<br \/>\ndescribed in the credit agreements)<\/li>\n<li style=\"text-align: justify;\">54-month maturity, with interest-only period of 30<br \/>\nmonths, which can be extended to 36 months subject to achievement of certain<br \/>\nperformance milestones<\/li>\n<\/ul>\n<p>The credit facility is secured by substantially all of the Company\u2019s assets. Additional<br \/>\ndetails regarding the Company\u2019s debt refinancing will be filed with the Securities and<br \/>\nExchange Commission on a Current Report on Form 8-K available at<br \/>\ninvestors.sightsciences.com.<\/p>\n<p><strong>About Sight Sciences<\/strong><br \/>\nSight Sciences is an eyecare technology company focused on developing and commercializing<br \/>\ninnovative solutions to transform care and improve patients\u2019 lives. Using minimally invasive<br \/>\nor non-invasive approaches to target the underlying causes of the world\u2019s most prevalent eye<br \/>\ndiseases, Sight Sciences seeks to create more effective treatment paradigms that enhance<br \/>\npatient care and supplant conventional, outdated approaches. The Company\u2019s OMNI<sup>\u00ae<\/sup><br \/>\nSurgical System is a MIGS technology indicated to reduce intraocular pressure in adult<br \/>\npatients with primary open-angle glaucoma (\u201cPOAG\u201d), the world\u2019s leading cause of<br \/>\nirreversible blindness. The Company\u2019s TearCare<sup>\u00ae<\/sup> System technology is 510(k)<br \/>\ncleared for the application of localized heat therapy in adult patients with evaporative dry<br \/>\neye disease due to meibomian gland dysfunction (\u201cMGD\u201d) when used in conjunction with manual<br \/>\nexpression of the meibomian glands, enabling office-based clearance of gland obstructions by<br \/>\nphysicians to address the leading cause of dry eye disease. The Company\u2019s SION<sup>\u00ae<\/sup><br \/>\nSurgical Instrument is a manually operated device used in ophthalmic surgical procedures to<br \/>\nexcise trabecular meshwork.<\/p>\n<p>For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EKZqxocw8HZvSXqivf1g7mrgj070qbrbncKt_RI4qGuCUvKtUaBz_hbGpFHWx_4tCqxi95Zqu3-WpgN6d82SUheOkup0uXYjTxGeQNmfDM-nMnjHe-Gh_DeNev-C8VKvJoE3g-sz4vcgM47IY-AMlmLdnP5zPjnKLhM919iGQegBiRMBDYDZd5LvIk91ck6ALdypnslBzqdJUzOouU6ySU6ZN-djtzlx-kKkOzoNLyMFUcFiuthPrXpQiWzp4arQG6qgW5t9LWIebt0AUGzRDw==\" target=\"_blank\" rel=\"nofollow noopener\">www.sightsciences.com<\/a>.<br \/>\nOMNI, SION, and TearCare are registered trademarks of Sight Sciences, Inc.<br \/>\n\u00a9 2024 Sight Sciences. All rights reserved.<\/p>\n<p><strong>Forward-Looking Statements<\/strong><br \/>\nThis press release, together with other statements and information publicly disseminated by<br \/>\nthe Company, contains certain forward-looking statements within the meaning of Section 27A<br \/>\nof the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of<br \/>\n1934, as amended, which statements are subject to considerable risks and uncertainties. The<br \/>\nCompany intends such forward-looking statements to be covered by the safe harbor provisions<br \/>\nfor forward-looking statements contained in the Private Securities Litigation Reform Act of<br \/>\n1995 and includes this statement for purposes of complying with these safe harbor<br \/>\nprovisions. Any statements made in this press release that are not statements of historical<br \/>\nfact, including statements about our beliefs and expectations, are forward-looking<br \/>\nstatements and should be evaluated as such. Forward-looking statements herein include,<br \/>\nwithout limitation, statements concerning the terms of the new secured credit facility with<br \/>\nHercules including the amount of available borrowings, and the Company\u2019s ability to expand<br \/>\nits financial flexibility through the utilization of the credit facility with Hercules.<br \/>\nThese statements often include words such as \u201canticipate,\u201d \u201cexpect,\u201d \u201csuggests,\u201d \u201cplan,\u201d<br \/>\n\u201cbelieve,\u201d \u201cintend,\u201d \u201cestimates,\u201d \u201ctargets,\u201d \u201cprojects,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cmay,\u201d<br \/>\n\u201cwill,\u201d \u201cforecast\u201d and other similar expressions. We base these forward-looking statements<br \/>\non our current expectations, plans and assumptions that we have made in light of our<br \/>\nexperience in the industry, as well as our perceptions of historical trends, current<br \/>\nconditions, expected future developments and other factors we believe are appropriate under<br \/>\nthe circumstances at such time. Although management believes these forward-looking<br \/>\nstatements are based upon reasonable assumptions at the time they are made, management<br \/>\ncannot guarantee their accuracy or completeness. Forward-looking statements are subject to<br \/>\nand involve risks, uncertainties and assumptions that may cause the Company\u2019s actual<br \/>\nresults, performance or achievements to be materially different from any future results,<br \/>\nperformance, or achievements predicted, assumed or implied by such forward-looking<br \/>\nstatements. Some of the risks and uncertainties that may cause actual results to materially<br \/>\ndiffer from those expressed or implied by these forward-looking statements are discussed<br \/>\nunder the caption \u201cRisk Factors\u201d in the Company\u2019s filings with the SEC, as may be updated<br \/>\nfrom time to time in subsequent filings. These cautionary statements should not be construed<br \/>\nby you to be exhaustive and are made only as of the date of this press release. Sight<br \/>\nSciences undertakes no obligation to update or revise any forward-looking statements,<br \/>\nwhether as a result of new information, future events or otherwise, except as required by<br \/>\napplicable law.<br \/>\n<br class=\"\" \/><strong>Media contact:<\/strong><br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2QVvsawRXTSCZJZvhsHd66ReNlMiop_DkaVPLTvESX4LewEGB1NCpmhaULNHH1tcHyCAfrAqsTVVMB5UYhIjDQ0-GlUYKekIl5YLkzq5skM=\" target=\"_blank\" rel=\"nofollow noopener\">pr@SightSciences.com<\/a><br \/>\n<strong>Investor contact:<\/strong><br \/>\nPhilip Taylor<br \/>\nGilmartin Group<br \/>\n415.937.5406<br \/>\n<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CdshpPmYnQWgfqA05G9u4_58HN7geJAY58bYD0RoHFObpcgDbhWy1AnPzh4wl7HxWJGBaNN1QMLKVNU73M8sp-eMy9-MsSvDO7-U34PHbO8IvKvvZLEDEArnW6DFMSyF61EUZyys8jx4W0zbvdtwWg==\" target=\"_blank\" rel=\"nofollow noopener\">Investor.Relations@Sightsciences.com<\/a><\/p>\n<\/div>\n<\/article>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PDF Version &nbsp; Refinancing replaces prior senior credit facility MENLO PARK, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) &#8212; Sight Sciences, Inc. (Nasdaq: SGHT) (\u201cSight Sciences\u201d), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients\u2019 lives, today announced the closing of an up to $65 million senior [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-1206","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital - International<\/title>\n<meta name=\"description\" content=\"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital\" \/>\n<meta property=\"og:description\" content=\"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/\" \/>\n<meta property=\"og:site_name\" content=\"International\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-23T21:49:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-27T06:47:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sightsciences.com\/ous\/wp-content\/uploads\/sites\/3\/2024\/04\/SISC_RTS_Logo_Primary_RGB_P1-1200.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin-dev\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin-dev\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/\"},\"author\":{\"name\":\"admin-dev\",\"@id\":\"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/88f84507b2364aa1168168756f61f091\"},\"headline\":\"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital\",\"datePublished\":\"2024-01-23T21:49:04+00:00\",\"dateModified\":\"2024-05-27T06:47:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/\"},\"wordCount\":961,\"commentCount\":0,\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/\",\"url\":\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/\",\"name\":\"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital - International\",\"isPartOf\":{\"@id\":\"https:\/\/www.sightsciences.com\/ous\/#website\"},\"datePublished\":\"2024-01-23T21:49:04+00:00\",\"dateModified\":\"2024-05-27T06:47:34+00:00\",\"author\":{\"@id\":\"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/88f84507b2364aa1168168756f61f091\"},\"description\":\"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sightsciences.com\/ous\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sightsciences.com\/ous\/#website\",\"url\":\"https:\/\/www.sightsciences.com\/ous\/\",\"name\":\"International\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sightsciences.com\/ous\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/88f84507b2364aa1168168756f61f091\",\"name\":\"admin-dev\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g\",\"caption\":\"admin-dev\"},\"url\":\"https:\/\/www.sightsciences.com\/ous\/author\/admin-dev\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital - International","description":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/","og_locale":"en_US","og_type":"article","og_title":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital","og_description":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital","og_url":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/","og_site_name":"International","article_published_time":"2024-01-23T21:49:04+00:00","article_modified_time":"2024-05-27T06:47:34+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.sightsciences.com\/ous\/wp-content\/uploads\/sites\/3\/2024\/04\/SISC_RTS_Logo_Primary_RGB_P1-1200.png","type":"image\/png"}],"author":"admin-dev","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin-dev","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/#article","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/"},"author":{"name":"admin-dev","@id":"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/88f84507b2364aa1168168756f61f091"},"headline":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital","datePublished":"2024-01-23T21:49:04+00:00","dateModified":"2024-05-27T06:47:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/"},"wordCount":961,"commentCount":0,"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/","url":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/","name":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital - International","isPartOf":{"@id":"https:\/\/www.sightsciences.com\/ous\/#website"},"datePublished":"2024-01-23T21:49:04+00:00","dateModified":"2024-05-27T06:47:34+00:00","author":{"@id":"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/88f84507b2364aa1168168756f61f091"},"description":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital","breadcrumb":{"@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sightsciences.com\/ous\/sight-sciences-announces-the-closing-of-up-to-65-million-senior-secured-credit-facility-with-hercules-capital\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sightsciences.com\/ous\/"},{"@type":"ListItem","position":2,"name":"Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital"}]},{"@type":"WebSite","@id":"https:\/\/www.sightsciences.com\/ous\/#website","url":"https:\/\/www.sightsciences.com\/ous\/","name":"International","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sightsciences.com\/ous\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/88f84507b2364aa1168168756f61f091","name":"admin-dev","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sightsciences.com\/ous\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7b9b8f03f53de455547cff48e35299ac8abad46d269b304aaf6215427c968767?s=96&d=mm&r=g","caption":"admin-dev"},"url":"https:\/\/www.sightsciences.com\/ous\/author\/admin-dev\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/posts\/1206","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/comments?post=1206"}],"version-history":[{"count":0,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/posts\/1206\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/media?parent=1206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/categories?post=1206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sightsciences.com\/ous\/wp-json\/wp\/v2\/tags?post=1206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}